Identifying which treated hypertensive patients without known coronary artery disease should be tested for the presence of myocardial ischemia by perfusion imaging
- PMID: 18046097
- PMCID: PMC8110112
- DOI: 10.1111/j.1524-6175.2007.07284.x
Identifying which treated hypertensive patients without known coronary artery disease should be tested for the presence of myocardial ischemia by perfusion imaging
Abstract
Stress dipyridamole technetium-99(m) sestamibi single photon emission computed tomographic imaging was used to study myocardial perfusion in 1116 hypertensive patients without known coronary artery disease (CAD). The test confirmed the presence of CAD in 28.9% of patients. As expected, patients with diabetes mellitus (DM) had a significantly higher prevalence of myocardial perfusion abnormalities (35.9% vs 23.9%; odds ratio, 1.79; 95% confidence interval [CI], 1.38-2.33; P<.0001) and high-risk myocardial imaging (16.4% vs 10.6%; odds ratio, 1.67; 95% CI, 1.18-2.37; P=.004) than those without DM. Odd ratios further increased, again as expected, with dyslipidemia (2.19; 95% CI, 1.54-3.12; P<.0001), peripheral arterial disease (2.61; 95% CI, 1.77-3.85; P<.0001), microalbuminuria (3.03; 95% CI, 1.91-4.82; P<.0001), and abnormal electrocardiographic findings (3.06; 1.68; 95% CI, 2.08-4.48; P<.0001). This large cohort study showed that more than 1 of 4 treated hypertensive patients have subclinical CAD. These study data should be clinically helpful in selecting hypertensive patients who are the most suitable candidates to screen for the presence of CAD.
Figures





Similar articles
-
Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging.Can J Cardiol. 2006 Feb;22 Suppl A:16A-21A. Can J Cardiol. 2006. PMID: 16485055
-
The additive value of transient left ventricular dilation using two-day dipyridamole 99mTc-MIBI SPET for screening coronary artery disease in patients with otherwise normal myocardial perfusion: a comparison between diabetic and non-diabetic cases.Hell J Nucl Med. 2010 Sep-Dec;13(3):246-52. Hell J Nucl Med. 2010. PMID: 21193879 Clinical Trial.
-
Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients.Nuklearmedizin. 2011;50(1):3-8. doi: 10.3413/nukmed-0318-10-05. Epub 2010 Nov 5. Nuklearmedizin. 2011. PMID: 21052610
-
Gender differences in detecting coronary artery disease with dipyridamole stress myocardial perfusion imaging using 99m-Tc sestamibi gated SPECT.Prilozi. 2005 Aug;26(1):93-102. Prilozi. 2005. PMID: 16118618
-
Myocardial perfusion imaging in diabetes mellitus.Can J Cardiol. 2006 Feb;22 Suppl A:22A-25A. doi: 10.1016/s0828-282x(06)70975-8. Can J Cardiol. 2006. PMID: 16485056 Review.
References
-
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evolution and Treatment of High Blood Pressure. JAMA. 2003;289:2560–2572. - PubMed
-
- Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med. 1992;327:998–1008. - PubMed
-
- Concensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;9:1551–1559. - PubMed
-
- Thaulow E, Eriksson J. Prognosis implication of asymptomatic myocardial ischemia. Cardiology. 1994;85(suppl 2):11–15. - PubMed
-
- Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation. 1999;100:988–998. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous